Key Highlights
- Amazon shares climbed to an unprecedented $258.79, posting 41.4% gains year-over-year
- Current trading levels align closely with InvestingPro Fair Value assessment of $258.38
- BMO Capital elevated its price objective to $315, highlighting anticipated AWS momentum through mid-2026
- The company committed an extra $5 billion to Anthropic, preparing $20 billion in additional capital
- Ad revenue segment poised for uplift from Winter Olympics, FIFA World Cup, and election advertising cycles
Amazon shares peaked at $258.79 during Wednesday’s trading session, establishing a fresh record. The e-commerce and cloud computing giant has delivered 41.4% returns across the trailing twelve months, commanding a market capitalization approaching $2.78 trillion.
According to InvestingPro analytics, Amazon’s Fair Value sits at $258.38, suggesting the shares are trading at approximately accurate valuation levels. The platform assigns Amazon a “GREAT” score for financial health metrics.
BMO Capital upgraded its price objective on AMZN to $315 from $310 Wednesday morning, maintaining its Outperform designation. The investment firm continues to feature Amazon among its Top Pick selections.
BMO’s industry research indicates AWS expansion will gain momentum during early 2026. The acceleration stems from heightened requirements from AI laboratories combined with recent supply chain enhancements.
The firm expressed measured concern regarding retail operations. Macroeconomic volatility and geopolitical tensions present challenges for retail performance, although consumer spending remains resilient for now.
Cloud Computing and Artificial Intelligence Initiatives
Amazon’s deepened collaboration with Anthropic has captured widespread analyst interest. Amazon deployed an additional $5 billion, earmarking another $20 billion for future investment. Anthropic pledged to allocate over $100 billion toward AWS services throughout the coming decade.
UBS elevated its Amazon price target as well, advancing to $304 while sustaining a Buy recommendation. The firm highlighted recent AWS agreements with both OpenAI and Anthropic as significant revenue catalysts.
Roth/MKM confirmed its Buy stance with a $285 objective. Cantor Fitzgerald increased its target to $280, emphasizing robust AWS growth driven by AI laboratory requirements and supply chain optimization.
Truist Securities preserved its Buy rating, underscoring the Anthropic alliance as a pivotal expansion catalyst.
Diversified Growth Avenues
Regarding the advertising business, BMO Capital modestly increased its projections for this segment. The firm anticipates a cyclically favorable 2026, benefiting from Winter Olympics viewership, FIFA World Cup audiences, and election advertising spending.
Amazon revealed a collaboration with Swedish firm Einride to introduce 75 electric heavy-duty vehicles across five U.S. facilities. The fleet will operate using Einride’s Saga AI platform, which coordinates charging schedules and vehicle management.
Amazon introduced a weight management service through Amazon One Medical this week, integrating GLP-1 pharmaceutical options with primary care offerings. This announcement pressured Hims & Hers Health stock downward.
Amazon’s earnings disclosure is scheduled for April 29. InvestingPro analysts have identified 12 ProTips for investors evaluating the stock before that announcement. The equity currently carries a P/E ratio of 35.48.
As Wednesday’s session progressed, AMZN was changing hands at $255.36, hovering near its fresh 52-week peak of $258.79.
